Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells
- 26 July 2021
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 21 (13), 1689-1696
- https://doi.org/10.2174/1871520620666201106085227
Abstract
Background: High-risk human papillomavirus (HR-HPV) persistent infection is the main cause of cervical cancer and its precancerous lesions. A previous study showed that HPV16 and HPV58 infections were the most common infection types in the local region. Some studies also declared that HPV58 E7 variants increased the risk of cervical cancer among Asian populations. Objective: This study aimed to determine whether the HPV58 E7 T20I (C632T) variant promotes the malignant behavior of cervical cancer cells and the underlying mechanism of the HR-HPV E7 oncoprotein involved in the development of cervical cancer. Methods: CCK-8 and clone formation assays were used to detect cell proliferation ability. Transwell assays and cell wound healing assays were used to evaluate cell migration ability. Targeted knockdown of E2F1 expression using specific siRNA, RT-qPCR and Western blot were performed to assess gene expression changes. A chromatin immunoprecipitation assay was used to verify that E2F1 interacted with the TOP2A promoter region. Results: HPV58 E7 and HPV58 E7M oncoproteins increased the proliferation and migration ability of cervical cancer cells. However, the HPV58 E7 T20I variant did not promote malignant behaviors compared with wild-type HPV58 E7. HPV E7 and E7M oncoproteins increased the expression of TOP2A, BIRC5 and E2F1, and knockdown of HPV E7 decreased their expression. Low E2F1 expression reduced the expression of TOP2A and BIRC5 and inhibited the proliferation and migration ability of cervical cancer cells. E2F1 interacted with the TOP2A gene promoter region to promote its transcriptional expression. Conclusions: The HPV58 E7 T20I variant did not promote malignant behaviors compared with wild-type HPV58 E7. The HR-HPV E7 oncoprotein enhanced the proliferation and migration of cervical cancer cells, which was considered to be due to the HPV E7 oncoprotein increasing the expression of BIRC5 and TOP2A by upregulating the transcription factor E2F1.Keywords
Funding Information
- First Affiliated Hospital of Xi’an Jiaotong University (2016QN-27)
This publication has 28 references indexed in Scilit:
- Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological careJournal of Biomedical Science, 2016
- [Natural Outcome of Genital Tract High-risk Human Papillomavirus Infection and Associated Factors among 760 Women].2015
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV VaccinesJNCI Journal of the National Cancer Institute, 2015
- Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and CancerBioMed Research International, 2013
- Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variationsInternational Journal of Cancer, 2012
- Identification and validation of genes involved in cervical tumourigenesisBMC Cancer, 2011
- Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastomaCancer Letters, 2009
- Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapyVirology, 2004
- Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent MannerOnline Journal of Public Health Informatics, 2002
- The Retinoblastoma Gene: A Prototypic and Multifunctional Tumor SuppressorExperimental Cell Research, 2001